
BPC-157
Also called Body Protection Compound 157
- Evidence
- Limited research
- Class
- Synthetic pentadecapeptide (gastric-derived)
BPC-157 belongs to the Synthetic pentadecapeptide (gastric-derived) class. This library groups it under digestive & weight. Its source category is Not FDA-approved.
At a glance
| Compound class | Synthetic pentadecapeptide (gastric-derived) |
|---|---|
| Body system | Digestive & weight |
| Use or research focus | Tendon/ligament/gut injury, recovery |
| Regulatory status | Not FDA-approved; PCAC voted favorably (Jul 2026) for 503A compounding — final FDA rule pending |
| Source evidence rating | Limited research |
How does BPC-157 work?
Promotes angiogenesis, tendon/gut healing (mechanism not fully established).
The source catalog maps this mechanism to Gut / GI, Joints / Connective tissue. A biological mechanism describes how a compound interacts with the body; it does not by itself prove a clinical benefit.
What does the evidence tell us?
The source catalog rates the evidence as limited. Laboratory and animal findings cannot establish benefits or safety in people. Small or early studies may raise useful research questions without supporting routine clinical use.
Use the Citations tab to examine the underlying sources. Look for human studies, a relevant comparison group, meaningful outcomes, and adequate follow-up. An ingredient, approved drug, and compounded preparation may have different evidence.
Safety and considerations
For an unapproved use or compound, safety and effectiveness may be uncertain. Products sold for research are not a substitute for prescribed care. Do not infer a human dose, injection protocol, or treatment recommendation from preclinical research.
This library is educational and does not provide dosing or treatment instructions. A listing here does not indicate that Peppy offers the compound.
Common questions
What is BPC-157?
BPC-157 belongs to the Synthetic pentadecapeptide (gastric-derived) class. This library groups it under digestive & weight. Its source category is Not FDA-approved. Its recorded use or research focus is: Tendon/ligament/gut injury, recovery.
Is BPC-157 FDA-approved?
The catalog records: Not FDA-approved; PCAC voted favorably (Jul 2026) for 503A compounding — final FDA rule pending. Check the current product-specific regulatory information in the source links; a source category does not establish approval for every use or formulation.
How strong is the research?
The source catalog rates the evidence as limited. Laboratory and animal findings cannot establish benefits or safety in people. Small or early studies may raise useful research questions without supporting routine clinical use.
Where can I read the research?
The Citations tab contains 14 reference links from the source dataset. The original research guide provides additional context. These links are a starting point for reading the evidence.
More for digestive & weight
Factual catalog fields and citation links are adapted from Superpower’s BPC-157 guide and the public dataset linked in the reference post. Peppy’s explanations are educational; this page does not represent an independent clinical review of every linked study.
Sources & further reading
References associated with BPC-157 in the source dataset. Open a source to review its study design, population, limitations, and date.
- 01pentadecapeptidedoi.org
- 02“cytoprotective” agentdoi.org
- 032026 STAT News profilestatnews.com
- 042025 systematic reviewdoi.org
- 05NCT02637284clinicaltrials.gov
- 06503A bulk drug substances listfda.gov
- 07nominators withdrew their nominationsfda.gov
- 08Pharmacy Compounding Advisory Committee voted in favorstatnews.com
- 09prohibited at all times in sportusada.org
- 102019 reviewdoi.org
- 11BPC-157 improved tendon strength, elasticity, and functionpubmed.ncbi.nlm.nih.gov
- 12ClinicalTrials.govClinicalTrials.gov
- 132025 systematic reviewpubmed.ncbi.nlm.nih.gov
- 14WADA Prohibited Listwada-ama.org





